Use of a Smartphone App to Explore Potential Underuse of Prophylactic Aspirin for Preeclampsia. Issue 4 (April 2022)

• Record Type: Journal Article
• Authors: Krishnamurti, Tamar; Davis, Alexander L.; Rodriguez, Samantha; Hayani, Laila; Bernard, Miriam; Simhan, Hyagriv N.
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 4(2022)
• Page Start: 206
• Page End: 208
• Publication Date: 2022-04
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000827232.41429.82
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from JAMA Netw Open 2021;4:e2130804) Preeclampsia is a leading factor associated with maternal and neonatal morbidity and mortality. Effective prophylaxis can be achieved with low-dose aspirin (LDASA) 75 to 150 mg daily during pregnancy if initiated early in moderate- to high-risk patients.